524636 — Oxygenta Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹4.45bn
- IN₹5.07bn
- IN₹1.09bn
- 18
- 12
- 92
- 34
Annual cashflow statement for Oxygenta Pharmaceutical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 31.4 | -4.89 | -114 | -139 | -144 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 17.6 | 9.2 | 14.8 | 16.5 | 16.7 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -75.1 | -35.8 | 64 | -34.9 | 117 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.2 | -16.8 | -16.3 | -130 | 26 |
| Capital Expenditures | -67.4 | -49.5 | -96.4 | -41.1 | -114 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.225 | 0.045 | 0.05 | 0.179 | 1.42 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -67.2 | -49.4 | -96.4 | -40.9 | -112 |
| Financing Cash Flow Items | -17.8 | -9.25 | -14.9 | -15.9 | -17.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 86.7 | 63.3 | 112 | 171 | 86.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.27 | -2.89 | -0.495 | -0.054 | 0.209 |